True true, but other companies, or at least some of them, haven't had such disastrous management, and frankly, bad luck (giving GC some slack here). We all know there is huge potential value in these advances, but if no one has the interest and cash to buy and develop them and the company can't create excitement and raise the cash, then spend it VERY intelligently, we are for naught.
That's the pessimistic take. The optimist says that THIS time GC will actually deliver, an awesome team is being assembled, an announcement of new funding and settlement with toxic is forthcoming.
If only.....
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links